[Corrigendum] miR‑29a inhibits human retinoblastoma progression by targeting STAT3.

Following the publication of this article, an interested reader drew to the authors' attention that some western blotting data bands had apparently been duplicated in Fig. 4D. The authors have re‑examined their original data, and realized that this figure was assembled incorrectly. The corrected version of Fig. 4 is shown below. The authors sincerely apologize for the errors that were introduced during the preparation of this figure, and thank the Editor for allowing them the opportunity to publish a Corrigendum. Furthermore, they regret any inconvenience caused to the readership. [the original article was published in Oncology Reports 39: 739-746, 2018; DOI: 10.3892/or.2017.6144].